Abzena

Abzena company information, Employees & Contact Information

Explore related pages

Related company profiles:

Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.

Company Details

Employees
428
Founded
-
Address
6325 Lusk Blvd, San Diego,california 92121,united States
Phone
215-788-3603
Email
in****@****ena.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
abzena.com
HQ
San Diego, California
Looking for a particular Abzena employee's phone or email?

Abzena Questions

News

Orion and Abzena announce exclusive commercial license for Abzena’s antibody - GlobeNewswire

Orion and Abzena announce exclusive commercial license for Abzena’s antibody GlobeNewswire

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer - PR Newswire

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer PR Newswire

Abzena - Contract Pharma

Abzena Contract Pharma

Abzena Strengthens Executive Leadership Team with the Appointment of Taylor Boyd as CBO - PR Newswire

Abzena Strengthens Executive Leadership Team with the Appointment of Taylor Boyd as CBO PR Newswire

Abzena Appoints Dr Moncef Slaoui to Board - citybiz

Abzena Appoints Dr Moncef Slaoui to Board citybiz

Abzena expands QC testing at San Diego site - BioProcess International

Abzena expands QC testing at San Diego site BioProcess International

How Biotech Leader Abzena Uses Tech to Meet Medical Needs - Technology Magazine

How Biotech Leader Abzena Uses Tech to Meet Medical Needs Technology Magazine

Abzena earmarks $5M to bolster ADC, complex biologic services at Pennsylvania site - Fierce Pharma

Abzena earmarks $5M to bolster ADC, complex biologic services at Pennsylvania site Fierce Pharma

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer - CHEManager

Abzena Appoints Geoffrey M. Glass as Chief Executive Officer CHEManager

Abzena Introduces New GS Knockout Platforms - Contract Pharma

Abzena Introduces New GS Knockout Platforms Contract Pharma

Abzena, Argonaut partner to expedite drug development - BioProcess International

Abzena, Argonaut partner to expedite drug development BioProcess International

Abzena Announces Major Investment in Bioconjugation and ADC Capabilities in Response to Increasing Industry Demand - PR Newswire

Abzena Announces Major Investment in Bioconjugation and ADC Capabilities in Response to Increasing Industry Demand PR Newswire

Abzena scales up bioconjugation capacity with PA expansion - BioProcess International

Abzena scales up bioconjugation capacity with PA expansion BioProcess International

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies - PR Newswire

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies PR Newswire

Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers - GlobeNewswire

Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers GlobeNewswire

Abzena Appoints Taylor Boyd as CBO - Contract Pharma

Abzena Appoints Taylor Boyd as CBO Contract Pharma

In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board - Fierce Pharma

In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board Fierce Pharma

Abzena Partners with Argonaut to Offer Drug Development and Manufacturing Support for Biopharma Companies - Genetic Engineering and Biotechnology News

Abzena Partners with Argonaut to Offer Drug Development and Manufacturing Support for Biopharma Companies Genetic Engineering and Biotechnology News

Manufacturing roundup: Symbiosis, BioGrad, Abzena, Eschbach and more - European Pharmaceutical Review

Manufacturing roundup: Symbiosis, BioGrad, Abzena, Eschbach and more European Pharmaceutical Review

Pfizer bolsters North Carolina manufacturing footprint with Abzena plant purchase - Fierce Pharma

Pfizer bolsters North Carolina manufacturing footprint with Abzena plant purchase Fierce Pharma

Abzena nabs $65M to bolster manufacturing and research services on both sides of the pond - Fierce Pharma

Abzena nabs $65M to bolster manufacturing and research services on both sides of the pond Fierce Pharma

Abzena's New GMP Manufacturing Facility, Sanford, NC - Pharmaceutical Technology

Abzena's New GMP Manufacturing Facility, Sanford, NC Pharmaceutical Technology

Abzena appoints Dr. Moncef Slaoui to board of directors - SelectScience

Abzena appoints Dr. Moncef Slaoui to board of directors SelectScience

Abzena Expands Partnership With ProteoNic To Include 2G UNic® Technology As Standard Offering for All Customers - Technology Networks

Abzena Expands Partnership With ProteoNic To Include 2G UNic® Technology As Standard Offering for All Customers Technology Networks

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications - Nature

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications Nature

Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego - Pharmaceutical Technology

Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego Pharmaceutical Technology

Abzena Invests $60 M in New Biomanufacturing Facility - DCAT Value Chain Insights

Abzena Invests $60 M in New Biomanufacturing Facility DCAT Value Chain Insights

Expert Statement: Gavin Murdoch, Abzena - CHEManager

Expert Statement: Gavin Murdoch, Abzena CHEManager

Pfizer Acquires Abzena’s Biologic Manufacturing Facility - TechTarget

Pfizer Acquires Abzena’s Biologic Manufacturing Facility TechTarget

Richard Milbank joins Abzena - Cleanroom Technology

Richard Milbank joins Abzena Cleanroom Technology

Abzena Announces Appointment of Elaine Sapinoso as Global Head of Quality - BioSpace

Abzena Announces Appointment of Elaine Sapinoso as Global Head of Quality BioSpace

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance - Frontiers

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance Frontiers

Abzena licenses PSMA antibodies to Telix to create cancer-targeting radioactive drugs - Fierce Biotech

Abzena licenses PSMA antibodies to Telix to create cancer-targeting radioactive drugs Fierce Biotech

Abzena Buys CDMO PacificGMP for $8.4M - Genetic Engineering and Biotechnology News

Abzena Buys CDMO PacificGMP for $8.4M Genetic Engineering and Biotechnology News

Detection and Reduction of Immunogenicity - Genetic Engineering and Biotechnology News

Detection and Reduction of Immunogenicity Genetic Engineering and Biotechnology News

Top Abzena Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant